Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockAnuh Pharma Ltd (ANUHPHR) is currently trading at 77.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Anuh Pharma Limited is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, prominently serving the antibiotics, erythromycin salts, and chloramphenicol market segments. Recently, Anuh Pharma has expanded its production capacity by commissioning an additional intermediate block, enhancing its capability to produce APIs and meet growing market demands. The company reported a 21.14% revenue growth in H1 FY 2025 compared to H1 FY 2024. However, a decline in EBITDA highlights challenges due to reduced high-margin product sales and non-recurring expenses. A continued focus on mature markets and dedicated R&D efforts in diabetic care and anti-malarial therapies further showcases Anuh Pharma's strategic initiatives to drive future growth. Anuh Pharma's commitment to clean energy and environmental responsibility is evident with new solar power installations and increased effluent treatment capacity to support sustainable operations.
Over the past 52 weeks, Anuh Pharma Ltd has traded between a low of ₹68.00 and a high of ₹115.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Anuh Pharma Ltd has a market capitalization of approximately 773.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Anuh Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 18.44 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 773.63 Cr, Anuh Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Anuh Pharma Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Anuh Pharma Ltd is 18.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
5
Neutral
7
Bullish
2
Bearish
31
Neutral
7
Bullish
8
Bearish
26
Neutral
0
Bullish
6
Anuh Pharma Limited is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and bulk drugs, prominently serving the antibiotics, erythromycin salts, and chloramphenicol market segments.
Recently, Anuh Pharma has expanded its production capacity by commissioning an additional intermediate block, enhancing its capability to produce APIs and meet growing market demands.
The company reported a 21.14% revenue growth in H1 FY 2025 compared to H1 FY 2024. However, a decline in EBITDA highlights challenges due to reduced high-margin product sales and non-recurring expenses.
A continued focus on mature markets and dedicated R&D efforts in diabetic care and anti-malarial therapies further showcases Anuh Pharma's strategic initiatives to drive future growth.
Anuh Pharma's commitment to clean energy and environmental responsibility is evident with new solar power installations and increased effluent treatment capacity to support sustainable operations.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
774 Cr
Low Risk
18.4
56.7
1.2
2.4
115.00
68.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1098.00 | 1,113 Cr | 26.13 | 4.88 | 0.00 | 18.96 | 18.07 | 0.00 | |
326.90 | 958 Cr | 10.89 | 2.45 | 0.76 | 28.46 | 27.38 | 13.04 | |
77.00 | 774 Cr | 18.44 | 2.37 | 0.97 | 11.84 | 15.90 | 8.22 | |
217.00 | 338 Cr | 38.75 | 3.09 | 0.00 | 8.14 | 13.29 | 5.02 | |
303.00 | 297 Cr | 50.42 | 4.10 | 0.00 | 0.00 | 0.00 | 2.46 | |
10.99 | 267 Cr | 14.44 | 1.25 | 0.00 | 7.77 | 8.53 | 5.49 | |
70.19 | 200 Cr | 66.22 | 1.38 | 0.00 | 2.41 | 5.22 | 1.17 |
